FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383483802> ?p ?o ?g. }

• W4383483802 endingPage "443" @default.
• W4383483802 startingPage "431" @default.
• W4383483802 abstract "Recent studies suggest RNAs act as promising drug targets. However, limited development has been achieved in detecting RNA-ligand interactions. To guide the discovery of RNA-binding ligands, it is necessary to characterize them comprehensively, especially in the binding specificity, binding affinity and drug-like properties. We established a database, RNALID (http://biomed.nscc-gz.cn/RNALID/html/index.html#/database), which collects RNA-ligand interactions validated by low-throughput experiment. RNALID contains 358 RNA-ligand interactions. Comparing to the fellow database, 94.5% of ligands in RNALID are completely or partially novel collections, and 51.78% have novel two-dimensional (2D) structures. Through the analysis of ligand structure, binding affinity and cheminformatic parameters we found that multivalent (MV) ligands mainly binding to RNA repeats are more structurally conserved in both 2D and 3D structures than other ligand types, exhibit higher binding specificity and binding affinity than ligands binding to non-repeat RNAs, but deviate far from the Lipinski's rule of five. In contrary, small molecule (SM) ligands binding to virus RNA exhibit higher affinity and more resemble protein-ligands, but potentially possess low binding specificity. Further analysis on 28 detailed drug-likeness properties indicated that RNA-ligands' development need to balance between the binding affinity and the drug-likeness because of the significant linear co-relationship between the two. Comparing RNALID ligands to FDA-approved drugs and ligands without bioactivity indicated that RNA-binding ligands are different from them in chemical properties, structural properties and drug-likeness. Thus, characterizing the RNA-ligand interactions in RNALID in multiple respects provides new insights into discovering and designing druggable ligands binding with RNA." @default.
• W4383483802 created "2023-07-08" @default.
• W4383483802 creator A5023539493 @default.
• W4383483802 creator A5072520554 @default.
• W4383483802 creator A5076568855 @default.
• W4383483802 creator A5076815748 @default.
• W4383483802 creator A5092419737 @default.
• W4383483802 date "2023-07-06" @default.
• W4383483802 modified "2023-09-26" @default.
• W4383483802 title "Characterizing RNA-binding ligands on structures, chemical information, binding affinity and drug-likeness" @default.
• W4383483802 cites W1906610597 @default.
• W4383483802 cites W1973079932 @default.
• W4383483802 cites W1981737096 @default.
• W4383483802 cites W1989872688 @default.
• W4383483802 cites W1990414972 @default.
• W4383483802 cites W2008505552 @default.
• W4383483802 cites W2009313526 @default.
• W4383483802 cites W2012553029 @default.
• W4383483802 cites W2018408116 @default.
• W4383483802 cites W2018518196 @default.
• W4383483802 cites W2029919331 @default.
• W4383483802 cites W2038532324 @default.
• W4383483802 cites W2076498053 @default.
• W4383483802 cites W2096864392 @default.
• W4383483802 cites W2137052779 @default.
• W4383483802 cites W2159859043 @default.
• W4383483802 cites W2165694975 @default.
• W4383483802 cites W2169678694 @default.
• W4383483802 cites W2170146596 @default.
• W4383483802 cites W2204695023 @default.
• W4383483802 cites W2206542436 @default.
• W4383483802 cites W2275367538 @default.
• W4383483802 cites W2346030347 @default.
• W4383483802 cites W2346236193 @default.
• W4383483802 cites W2442594675 @default.
• W4383483802 cites W2504782965 @default.
• W4383483802 cites W2593488635 @default.
• W4383483802 cites W2747225324 @default.
• W4383483802 cites W2767891136 @default.
• W4383483802 cites W2789748145 @default.
• W4383483802 cites W2790048761 @default.
• W4383483802 cites W2820941669 @default.
• W4383483802 cites W2886497073 @default.
• W4383483802 cites W2913379802 @default.
• W4383483802 cites W2925065138 @default.
• W4383483802 cites W2947478096 @default.
• W4383483802 cites W2955754664 @default.
• W4383483802 cites W2979630284 @default.
• W4383483802 cites W298171742 @default.
• W4383483802 cites W2995106424 @default.
• W4383483802 cites W3003607774 @default.
• W4383483802 cites W3023385275 @default.
• W4383483802 cites W3080241033 @default.
• W4383483802 cites W3084513853 @default.
• W4383483802 cites W3138553748 @default.
• W4383483802 cites W4205126761 @default.
• W4383483802 cites W4221101432 @default.
• W4383483802 cites W4284958714 @default.
• W4383483802 cites W4309561400 @default.
• W4383483802 cites W4309670138 @default.
• W4383483802 doi "https://doi.org/10.1080/15476286.2023.2231708" @default.
• W4383483802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37415294" @default.
• W4383483802 hasPublicationYear "2023" @default.
• W4383483802 type Work @default.
• W4383483802 citedByCount "0" @default.
• W4383483802 crossrefType "journal-article" @default.
• W4383483802 hasAuthorship W4383483802A5023539493 @default.
• W4383483802 hasAuthorship W4383483802A5072520554 @default.
• W4383483802 hasAuthorship W4383483802A5076568855 @default.
• W4383483802 hasAuthorship W4383483802A5076815748 @default.
• W4383483802 hasAuthorship W4383483802A5092419737 @default.
• W4383483802 hasBestOaLocation W43834838021 @default.
• W4383483802 hasConcept C104317684 @default.
• W4383483802 hasConcept C107824862 @default.
• W4383483802 hasConcept C116569031 @default.
• W4383483802 hasConcept C12554922 @default.
• W4383483802 hasConcept C170493617 @default.
• W4383483802 hasConcept C185592680 @default.
• W4383483802 hasConcept C21951064 @default.
• W4383483802 hasConcept C41282012 @default.
• W4383483802 hasConcept C51639874 @default.
• W4383483802 hasConcept C55493867 @default.
• W4383483802 hasConcept C67705224 @default.
• W4383483802 hasConcept C70721500 @default.
• W4383483802 hasConcept C71240020 @default.
• W4383483802 hasConcept C74187038 @default.
• W4383483802 hasConcept C86803240 @default.
• W4383483802 hasConcept C96739231 @default.
• W4383483802 hasConceptScore W4383483802C104317684 @default.
• W4383483802 hasConceptScore W4383483802C107824862 @default.
• W4383483802 hasConceptScore W4383483802C116569031 @default.
• W4383483802 hasConceptScore W4383483802C12554922 @default.
• W4383483802 hasConceptScore W4383483802C170493617 @default.
• W4383483802 hasConceptScore W4383483802C185592680 @default.
• W4383483802 hasConceptScore W4383483802C21951064 @default.
• W4383483802 hasConceptScore W4383483802C41282012 @default.
• W4383483802 hasConceptScore W4383483802C51639874 @default.
• W4383483802 hasConceptScore W4383483802C55493867 @default.

• next